Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Vertex (NASDAQ:VERX) in the last three months. The table below provides a snapshot of their ...